 |
|
|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals is a Palo Alto-based company focused on improving the lives of patients through the development and commercialization of pharmaceutical products that treat neurologic and psychiatric disorders. Jazz Pharmaceuticals is creating innovative therapeutics by improving and expanding the uses of known compounds, and is aggressively adding to its pharmaceutical product portfolio through licensing, acquisitions and collaborations.
|
|
|
|
Industry: |
Healthcare – Specialty Pharmaceuticals |
Headquarters: |
Palo Alto, California |
Date of Investment: |
April 2004 |
Fund: |
WCP Fund I |
|
|
|
|
| |
|
|
“Waud Capital is an important group within our distinguished team of investors. The firm’s network of contacts and experience investing in the  healthcare industry should bring value as we build our business.”
Dr. Sam Saks, CEO, Jazz Pharmaceuticals
|
|
|
